Search Results 151-160 of 16970 for Antagonist
Has previously used a TNF-alpha antagonists (except adalimumab), and discontinued its use due to reasons other than safety, or; Is naïve to TNF-alpha antagonist ...
Learn how doctors use innovative operations, such as transoral robotic surgery, and radiation technology, including protons, for tongue cancer treatment.
Prior treatment with CYP17 inhibitors (e.g. TAK-700, ketoconazole*) or AR antagonists (e.g. enzalutamide, ARN-509,) or galeterone - abiraterone refractory only ...
Learn about these cancers that start in the hormone-producing cells of the pancreas. Explore innovative treatments, including the Whipple procedure and ...
The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with ...
For any other TNF-α antagonist, the participant must demonstrate signs and ... antagonists, or rituximab. Has had prior exposure to vedolizumab. Has a ...
Dr. Haak's research group is actively developing a D2 dopamine receptor antagonist for the treatment of PVR and a D1 dopamine receptor agonist for the treatment ...
... antagonist, and interleukin 5 receptor antagonist following endoscopic sinus surgery versus control in patient with chronic sinusitis with nasal polyps ...
or any other CRF1 receptor antagonist - Current treatment with dexamethasone as GC therapy for CAH. Prior treatment with dexamethasone is allowed as long as ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.